MASCC/ESMO Antiemetic Guidelines: Introduction to the 2016 guideline update

Excerpt

The Multinational Association for Supportive Care in Cancer (MASCC), the largest international society focusing on supportive care in patients with cancer across the entire cancer trajectory, convened a group of experts in 1997 to develop the first clinical guidelines for managing nausea and vomiting related to cancer treatments. Since then, with the development of new antiemetic drugs and the significant amount of new publications on nausea and vomiting, MASCC organized an update consensus meetings in 2004 and in 2009 in Perugia, Italy. In the latter meeting, MASCC joined with the European Society of Medical Oncology (ESMO) to update the guidelines using wider expertise from two large and leading societies and to avoid duplication of the work. Hence, the guidelines were updated and subsequently published in 2010 [1]. …